| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2567660 | Pulmonary Pharmacology & Therapeutics | 2010 | 10 Pages |
Abstract
These results suggest that IKKβ/IKK2 inhibitor PHA-408 is a powerful anti-inflammatory agent against LPS- and CS-mediated lung inflammation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Saravanan Rajendrasozhan, Jae-Woong Hwang, Hongwei Yao, Nandini Kishore, Irfan Rahman,